679 related articles for article (PubMed ID: 37892237)
1. Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A; Cobb MH
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892237
[TBL] [Abstract][Full Text] [Related]
2. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
[TBL] [Abstract][Full Text] [Related]
3. IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.
Jameson KL; Mazur PK; Zehnder AM; Zhang J; Zarnegar B; Sage J; Khavari PA
Nat Med; 2013 May; 19(5):626-630. PubMed ID: 23603816
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
6. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions.
Keshet Y; Seger R
Methods Mol Biol; 2010; 661():3-38. PubMed ID: 20811974
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 MAP kinases: structure, function, and regulation.
Roskoski R
Pharmacol Res; 2012 Aug; 66(2):105-43. PubMed ID: 22569528
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
9. Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs.
Yue J; Lai F; Beckedorff F; Zhang A; Pastori C; Shiekhattar R
Genes Dev; 2017 Sep; 31(17):1809-1820. PubMed ID: 28982763
[TBL] [Abstract][Full Text] [Related]
10. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
[No Abstract] [Full Text] [Related]
12. Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.
Marampon F; Ciccarelli C; Zani BM
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126017
[TBL] [Abstract][Full Text] [Related]
13. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
14. Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.
Eblen ST
Adv Cancer Res; 2018; 138():99-142. PubMed ID: 29551131
[TBL] [Abstract][Full Text] [Related]
15. Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields.
Kapri-Pardes E; Hanoch T; Maik-Rachline G; Murbach M; Bounds PL; Kuster N; Seger R
Cell Physiol Biochem; 2017; 43(4):1533-1546. PubMed ID: 29035881
[TBL] [Abstract][Full Text] [Related]
16. The ERK cascade: a prototype of MAPK signaling.
Rubinfeld H; Seger R
Mol Biotechnol; 2005 Oct; 31(2):151-74. PubMed ID: 16170216
[TBL] [Abstract][Full Text] [Related]
17. Negative feedback regulation of the ERK1/2 MAPK pathway.
Lake D; Corrêa SA; Müller J
Cell Mol Life Sci; 2016 Dec; 73(23):4397-4413. PubMed ID: 27342992
[TBL] [Abstract][Full Text] [Related]
18. The activation of ERK1/2 and p38 mitogen-activated protein kinases is dynamically regulated in the developing rat visual system.
Oliveira CS; Rigon AP; Leal RB; Rossi FM
Int J Dev Neurosci; 2008; 26(3-4):355-62. PubMed ID: 18280691
[TBL] [Abstract][Full Text] [Related]
19. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR; Oliver KE; Farley JH
Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress.
Martinez R; Huang W; Samadani R; Mackowiak B; Centola G; Chen L; Conlon IL; Hom K; Kane MA; Fletcher S; Shapiro P
J Pharmacol Exp Ther; 2021 Jan; 376(1):84-97. PubMed ID: 33109619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
